Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)
批准号:
10662531
负责人:
LINDA A DIMEGLIO
金额:
$257.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-08 至 2027-05-31
关键词:
AdultBasic ScienceBudgetsCaliberClinicalComplementDiabetes MellitusEducationEducational CurriculumEffectivenessEndocrinologyEnsureFacultyFundingGeographyGoalsHealth Services ResearchIndividualInstitutionInsulin-Dependent Diabetes MellitusInvestigationLeadershipMedical StudentsMedicineMentored Clinical Scientist Development ProgramMentorsPathway interactionsPhysiciansPositioning AttributeProgram DevelopmentRecruitment ActivityResearchResearch PersonnelResearch SupportResourcesScholars ProgramScienceScientistStructureTrainingUnderrepresented Populationsbench to bedsidecareercareer developmentcatalystcohesioncohortdesigndirected attentionequity, diversity, and inclusionevidence baseexperienceinterestmentoring communitymultidisciplinarynext generationpatient orientedprogramsskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The prime objective of our multi-center National K12 “Diabetes-Docs: Physician-Scientist Career
Development Program” (DiabDocs) is to support the research career development of the next generation of
physician-scientists in basic and clinical diabetes for academic careers with a specific focus on type 1 diabetes
(T1D). Our structured K12 program is designed to provide a mentored research experience together with
tailored career development training. Given the historically low rates of persons under-represented in medicine
entering diabetes research careers, we propose and prioritize here intentional evidence-based effort toward
support and funding for these individuals. We propose these aims to achieve the DiabDocs program goals:
1) Create a national cohort of up-and-coming physician-scientist researchers, developing cohesion through
shared programmatic training cohort experiences including an annual retreat;
2) Expand the geographical and pipeline reach of current diabetes K12 programs so that diverse K12 Scholar
candidates can be trained locally while maintaining the historic strengths of the past diabetes K12 programs;
3) Develop an outstanding national mentor community to train diabetes physician-scientists and provide a
more visible pathway to research careers for medical students/residents/fellows by active recruitment
programs and inclusion in the DiabDocs retreat and educational programs;
4) Ensure consistency and effectiveness of mentoring, including directed attention to Diversity, Equity, and
Inclusion (DEI) across research centers through shared mentor training and resources.
In addition to our MPI structure, one of the distinguishing features of our program is the inclusion of all recently-
funded K12 Scholar program PIs and their experience as part of the DiabDocs Executive Leadership
Committee (ELC) complemented by addition of two Adult Endocrinology physician-scientists with expertise in
basic science, health services research, & DEI programs. In addition to these ELC investigators, we have
engaged diverse physician-scientists from 15 additional institutions without K12 programs in diabetes, but with
a strong interest in engaging with DiabDocs. These institutions bring a wealth of expertise including T32, K12,
P30, and CTSA funding. DiabDocs will leverage these resources as well as their wide curricula of study and
research experiences to provide our K12 scholars high quality training from a diverse faculty.
We anticipate funding 55 Scholar Years over 5 years with each Scholar spending up to 3 years on the K12, but
we budget for 2 year terms on average with 27-28 Scholars funded with the goal to obtain independent career
development funding such as a K08/K23. Our K12 scholars will be well-positioned to serve as catalysts for
multidisciplinary investigations bridging bench-to-bedside science leading to patient-centered discoveries. We
are confident that we will attract the highest caliber of applicants and mentor them toward impactful careers in
academic medicine as skilled physician-scientist leaders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)
-
批准号:10533617
-
项目类别:
-
资助金额:$257.97万
-
财政年份:2022
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)
-
批准号:10884718
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2022
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:9270544
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2015
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:8977292
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2015
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:9113605
-
项目类别:
-
资助金额:$45.86万
-
财政年份:2015
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:8616831
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2009
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:8076274
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2009
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:7938580
-
项目类别:
-
资助金额:$82.33万
-
财政年份:2009
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:8468694
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2009
-
负责人:LINDA A DIMEGLIO
-
依托单位:
Type 1 Diabetes TrialNet at Indiana University Clinical Center
-
批准号:8284464
-
项目类别:
-
资助金额:$42.49万
-
财政年份:2009
-
负责人:LINDA A DIMEGLIO
-
依托单位:
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7717503
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2007
-
负责人:LINDA A DIMEGLIO
-
依托单位:
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7606406
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2006
-
负责人:LINDA A DIMEGLIO
-
依托单位:
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS
-
批准号:7606374
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2006
-
负责人:LINDA A DIMEGLIO
-
依托单位:
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA
-
批准号:7606372
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2006
-
负责人:LINDA A DIMEGLIO
-
依托单位:
ORAL BISPHOSPHONATE THERAPY FOR ADULTS WITH OSTEOGENESIS IMPERFECTA
-
批准号:7606378
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2006
-
负责人:LINDA A DIMEGLIO
-
依托单位:
PATHOGENESIS OF OSTEOPOROSIS IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7379099
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2005
-
负责人:LINDA A DIMEGLIO
-
依托单位:
BISPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA
-
批准号:7205747
-
项目类别:
-
资助金额:$2.89万
-
财政年份:2005
-
负责人:LINDA A DIMEGLIO
-
依托单位:
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS
-
批准号:7205749
-
项目类别:
-
资助金额:$3.18万
-
财政年份:2005
-
负责人:LINDA A DIMEGLIO
-
依托单位:
CONTINUOUS INSULIN INFUSION VERSUS INSULIN INJECTION THERAPY
-
批准号:7205800
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:LINDA A DIMEGLIO
-
依托单位:
BIPHOSPHONATE THERAPY FOR OSTEOGENESIS IMPERFECTA
-
批准号:7379051
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2005
-
负责人:LINDA A DIMEGLIO
-
依托单位:
海外基金